Skip to main content
SpringerLink
Log in

MiR-135b promotes proliferation and invasion of osteosarcoma cells via targeting FOXO1

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

Recent data strongly suggest the important role of miRNAs in various cancer-related processes. Osteosarcoma (OS) is the most common primary cancer of the bone and usually leads to deaths due to its rapid proliferation and metastasis. Here, we demonstrated that compared with noncancerous bone tissues, miR-135b expression is frequently upregulated in OS specimens, inversely correlated with potential target-FOXO1 expression pattern. Bioinformatics analysis combined with experimental confirmation revealed FOXO1 is a direct target of miR-135b in OS. Functionally, miR-135b inhibitor significantly inhibited OS cells proliferation and invasion. Forced expression of FOXO1 showed the opposite effect, and FOXO1 knockdown abolished the effect of miR-135b inhibitor. Taken together, our data provide compelling evidence that miR-135b functions as an onco-miRNA in OS to promote OS cells proliferation and invasion, and its oncogenic effects are mediated chiefly through targeting FOXO1.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. He H, Ni J, Huang J (2014) Molecular mechanisms of chemoresistance in osteosarcoma. Oncol Lett 7:1352–1362

    PubMed Central  CAS  PubMed  Google Scholar 

  2. Yang J, Zhang W (2013) New molecular insights into osteosarcoma targeted therapy. Curr Opin Oncol 25:398–406

    Article  CAS  PubMed  Google Scholar 

  3. Sakamoto A, Iwamoto Y (2008) Current status and perspectives regarding the treatment of osteo-sarcoma: chemotherapy. Rev Recent Clin Trials 3:228–231

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  4. Croce CM, Calin GA (2005) miRNAs, cancer and stem cell division. Cell 122:6–7

    Article  CAS  PubMed  Google Scholar 

  5. Croce CM (2009) Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet 10:704–714

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  6. Di Leva G, Garofalo M, Croce CM (2014) MicroRNAs in cancer. Annu Rev Pathol 9:287–314

    Article  PubMed Central  PubMed  Google Scholar 

  7. Wu X, Zhong D, Gao Q, Zhai W, Ding Z, Wu J (2013) MicroRNA-34a inhibits human osteosarcoma proliferation by downregulating ether a go-go 1 expression. Int J Med Sci 10:676–682

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  8. Zhao H, Guo M, Zhao G, Ma Q, Ma B, Qiu X, Fan Q (2012) miR-183 inhibits the metastasis of osteosarcoma via downregulation of the expression of Ezrin in F5M2 cells. Int J Mol Med 30:1013–1020

    PubMed Central  CAS  PubMed  Google Scholar 

  9. Yang J, Gao T, Tang J, Cai H, Lin L, Fu S (2013) Loss of microRNA-132 predicts poor prognosis in patients with primary osteosarcoma. Mol Cell Biochem 381:9–15

    Article  CAS  PubMed  Google Scholar 

  10. Xu Y, Zhao F, Wang Z, Song Y, Luo Y, Zhang X, Jiang L, Sun Z, Miao Z, Xu H (2012) MicroRNA-335 acts as a metastasis suppressor in gastric cancer by targeting Bcl-w and specificity protein 1. Oncogene 31:1398–1407

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  11. Wu W, Wang Z, Yang P, Yang J, Liang J, Chen Y, Wang H, Wei G, Ye S, Zhou Y (2014) MicroRNA-135b regulates metastasis suppressor 1 expression and promotes migration and invasion in colorectal cancer. Mol Cell Biochem 388:249–259

    Article  CAS  PubMed  Google Scholar 

  12. Arigoni M, Barutello G, Riccardo F, Ercole E, Cantarella D, Orso F, Conti L, Lanzardo S, Taverna D, Merighi I, Calogero RA, Cavallo F, Quaglino E (2013) miR-135b coordinates progression of ErbB2-driven mammary carcinomas through suppression of MID1 and MTCH2. Am J Pathol 182:2058–2070

    Article  CAS  PubMed  Google Scholar 

  13. Lin CW, Chang YL, Chang YC, Lin JC, Chen CC, Pan SH, Wu CT, Chen HY, Yang SC, Hong TM, Yang PC (2013) MicroRNA-135b promotes lung cancer metastasis by regulating multiple targets in the Hippo pathway and LZTS1. Nat Commun 4:1877

    Article  PubMed  Google Scholar 

  14. Zhang L, Sun ZJ, Bian Y, Kulkarni AB (2013) MicroRNA-135b acts as a tumor promoter by targeting the hypoxia-inducible factor pathway in genetically defined mouse model of head and neck squamous cell carcinoma. Cancer Lett 331:230–238

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  15. Munding JB, Adai AT, Maghnouj A, Urbanik A, Zöllner H, Liffers ST, Chromik AM, Uhl W, Szafranska-Schwarzbach AE, Tannapfel A, Hahn SA (2012) Global microRNA expression profiling of microdissected tissues identifies miR-135b as a novel biomarker for pancreatic ductal adenocarcinoma. Int J Cancer 131:E86–E95

    Article  CAS  PubMed  Google Scholar 

  16. Matsuyama H, Suzuki HI, Nishimori H, Noguchi M, Yao T, Komatsu N, Mano H, Sugimoto K, Miyazono K (2011) miR-135b mediates NPM-ALK-driven oncogenicity and renders IL-17-producing immunophenotype to anaplastic large cell lymphoma. Blood 118:6881–6892

    Article  CAS  PubMed  Google Scholar 

  17. Bhinge A, Poschmann J, Namboori SC, Tian X, Jia Hui Loh S, Traczyk A, Prabhakar S, Stanton LW (2014) MiR-135b is a direct PAX6 target and specifies human neuroectoderm by inhibiting TGF-β/BMP signaling. EMBO J 33:1271–1283

    PubMed Central  CAS  PubMed  Google Scholar 

  18. Xu S, Cecilia Santini G, De Veirman K, Vande Broek I, Leleu X, De Becker A, Van Camp B, Vanderkerken K, Van Riet I (2013) Upregulation of miR-135b is involved in the impaired osteogenic differentiation of mesenchymal stem cells derived from multiple myeloma patients. PLoS One 8:e79752

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  19. Huang H, Tindall DJ (2007) Dynamic FoxO transcription factors. J Cell Sci 120:2479–2487

    Article  CAS  PubMed  Google Scholar 

  20. Huang H, Regan KM, Lou Z, Chen J, Tindall DJ (2006) CDK2-dependent phosphorylation of FOXO1 as an apoptotic response to DNA damage. Science 314:294–297

    Article  CAS  PubMed  Google Scholar 

  21. Greer EL, Brunet A (2005) FOXO transcription factors at the interface between longevity and tumor suppression. Oncogene 24:7410–7425

    Article  CAS  PubMed  Google Scholar 

  22. Li F, Liu B, Gao Y, Liu Y, Xu Y, Tong W, Zhang A (2014) Upregulation of microRNA-107 induces proliferation in human gastric cancer cells by targeting the transcription factor FOXO1. FEBS Lett 588:538–544

    Article  CAS  PubMed  Google Scholar 

  23. Dong XY, Chen C, Sun X, Guo P, Vessella RL, Wang RX, Chung LW, Zhou W, Dong JT (2006) FOXO1A is a candidate for the 13q14 tumor suppressor gene inhibiting androgen receptor signaling in prostate cancer. Cancer Res 66:6998–7006

    Article  CAS  PubMed  Google Scholar 

  24. Fendler A, Jung M, Stephan C, Erbersdobler A, Jung K, Yousef GM (2013) The antiapoptotic function of miR-96 in prostate cancer by inhibition of FOXO1. PLoS One 8:e80807

    Article  PubMed Central  PubMed  Google Scholar 

  25. Sangodkar J, Dhawan NS, Melville H, Singh VJ, Yuan E, Rana H, Izadmehr S, Farrington C, Mazhar S, Katz S, Albano T, Arnovitz P, Okrent R, Ohlmeyer M, Galsky M, Burstein D, Zhang D, Politi K, Difeo A, Narla G (2012) Targeting the FOXO1/KLF6 axis regulates EGFR signaling and treatment response. J Clin Invest 122:2637–2651

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  26. Li ZC, Zhang LM, Wang HB, Ma JX, Sun JZ (2014) Curcumin inhibits lung cancer progression and metastasis through induction of FOXO1. Tumour Biol 35:111–116

    Article  PubMed  Google Scholar 

  27. Chang YW, Zhao YF, Cao YL, Gu XF, Li ZQ, Wang SQ, Miao JH, Zhan HS (2013) Liver X receptor α inhibits osteosarcoma cell proliferation through up-regulation of FoxO1. Cell Physiol Biochem 32:180–186

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Orthopedics, Renmin Hospital of Wuhan University, Zhangzhidong Road 99#, Wuhan, 430060, Hubei, People’s Republic of China

    Hong Pei, Zhiliang Jin, Shunguang Chen, Xianglun Sun, Jie Yu & Weichun Guo

Authors
  1. Hong Pei
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zhiliang Jin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shunguang Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Xianglun Sun
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jie Yu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Weichun Guo
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Weichun Guo.

Additional information

Hong Pei and Zhiliang Jin have contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pei, H., Jin, Z., Chen, S. et al. MiR-135b promotes proliferation and invasion of osteosarcoma cells via targeting FOXO1. Mol Cell Biochem 400, 245–252 (2015). https://doi.org/10.1007/s11010-014-2281-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11010-014-2281-2

Keywords

Search

Navigation